Stratos Wealth Partners, LTD. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$1,343,136
+8.4%
13,186
+7.4%
0.03%
+3.6%
Q2 2023$1,238,895
+4.2%
12,277
-5.0%
0.03%
-12.5%
Q1 2023$1,189,125
-4.0%
12,925
-5.4%
0.03%
+3.2%
Q4 2022$1,238,901
+30.7%
13,656
+9.4%
0.03%
+19.2%
Q3 2022$948,000
-15.5%
12,478
-6.0%
0.03%
-7.1%
Q2 2022$1,122,000
+8.8%
13,277
+13.0%
0.03%
+21.7%
Q1 2022$1,031,000
-1.2%
11,754
-1.5%
0.02%0.0%
Q4 2021$1,043,000
+8.5%
11,929
+1.5%
0.02%
-4.2%
Q3 2021$961,000
-10.1%
11,748
+0.3%
0.02%
-11.1%
Q2 2021$1,069,000
-1.6%
11,716
-7.8%
0.03%
-10.0%
Q1 2021$1,086,000
-14.6%
12,710
-5.6%
0.03%
-21.1%
Q4 2020$1,271,000
-6.3%
13,461
-13.7%
0.04%
-15.6%
Q3 2020$1,356,000
-8.1%
15,598
-7.7%
0.04%
-15.1%
Q2 2020$1,476,000
+44.8%
16,899
+36.8%
0.05%
+12.8%
Q1 2020$1,019,000
+15.9%
12,357
+33.1%
0.05%
+34.3%
Q4 2019$879,000
+1.4%
9,281
-7.0%
0.04%
-5.4%
Q3 2019$867,000
-5.8%
9,981
-0.9%
0.04%
-7.5%
Q2 2019$920,000
-10.0%
10,072
-5.3%
0.04%
-13.0%
Q1 2019$1,022,000
+13.3%
10,631
+1.2%
0.05%
-2.1%
Q4 2018$902,000
+4.0%
10,506
+4.5%
0.05%
+20.5%
Q3 2018$867,000
+7.3%
10,058
-6.0%
0.04%
+8.3%
Q2 2018$808,000
-74.9%
10,696
-73.2%
0.04%
-73.5%
Q1 2018$3,225,000
-1.7%
39,889
+2.0%
0.14%
-7.5%
Q4 2017$3,282,000
-10.5%
39,094
-8.5%
0.15%
-15.0%
Q3 2017$3,666,000
+10.1%
42,706
+7.1%
0.17%
+0.6%
Q2 2017$3,329,000
-8.4%
39,884
-18.5%
0.17%
-16.1%
Q1 2017$3,634,000
+8.7%
48,931
+6.6%
0.20%
-1.4%
Q4 2016$3,342,000
+23.8%
45,884
+34.2%
0.21%
+14.3%
Q3 2016$2,699,000
+5.6%
34,187
+10.4%
0.18%
-3.7%
Q2 2016$2,555,000
+42.7%
30,969
+25.2%
0.19%
+22.7%
Q1 2016$1,791,000
+51.0%
24,728
+79.3%
0.15%
+55.6%
Q4 2015$1,186,000
-8.7%
13,789
-2.4%
0.10%
-39.3%
Q3 2015$1,299,000
+26.4%
14,134
+35.3%
0.16%
+23.5%
Q2 2015$1,028,000
-9.2%
10,449
-9.2%
0.13%
-2.2%
Q1 2015$1,132,000
+6.6%
11,513
+0.4%
0.14%
-29.3%
Q4 2014$1,062,000
+12.9%
11,463
+14.6%
0.19%
-13.6%
Q3 2014$941,000
+9.2%
10,001
+5.3%
0.22%
-23.0%
Q2 2014$862,0009,4950.29%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders